HeadlinesBriefing favicon HeadlinesBriefing.com

Pharming Shares Surge on Strong 2026 Guidance

Investing.com •
×

Shares of Pharming Group NV (PHAR) jumped over 6% on Tuesday. The biopharmaceutical company's 2026 financial guidance exceeded analyst expectations. Despite a recent setback for its Joenja treatment, Pharming projected total revenue between $405 million and $425 million, representing 8% to 13% growth.

This positive outlook signals investor confidence in the company's future.